Additional evidence suggests that GPR120, a GPCR for omega-3 fatty acid, seems to counteract oxidized-LDL/P2Y2-mediated inflammation in atherosclerosis, inhibiting the binding of monocytes to ECs [83]. This evidence concerns the gene P2RY2 and atherosclerosis.